Lilly (Eli) (LLY)
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$1149.36-0.88%
Close 2026-09-04 · 1-day change
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · LLY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 79,665.0 | 65,179.0 | 45,042.7 | 34,124.0 | 28,541.4 | 28,318.4 | 24,539.8 | 22,319.5 | 18,312.8 | 21,222.1 | 21,222.1 | 19,958.7 | 22,603.4 | 22,603.4 | 22,603.4 | 24,286.5 | 20,371.9 | 20,371.9 |
| Total Revenues | 79,665.0 | 65,179.0 | 45,042.7 | 34,124.0 | 28,541.4 | 28,318.4 | 24,539.8 | 22,319.5 | 18,312.8 | 21,222.1 | 21,222.1 | 19,958.7 | 22,603.4 | 22,603.4 | 22,603.4 | 24,286.5 | 20,371.9 | 20,371.9 |
| Cost of Revenues | 13,224.0 | 11,052.0 | 8,418.3 | 7,082.0 | 6,629.8 | 7,312.8 | 5,483.3 | 4,721.2 | 4,160.5 | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 12,237.0 | 11,094.0 | 8,593.8 | 7,404.0 | 6,440.4 | 6,431.6 | 6,121.2 | 6,213.8 | 5,841.9 | 6,452.0 | 6,452.0 | 6,533.0 | 7,513.5 | 7,513.5 | 7,513.5 | 7,879.9 | 6,626.4 | 6,626.4 |
| R&D Expenses | — | — | — | — | 7,190.8 | 6,930.7 | 5,976.3 | 5,595.0 | 5,040.0 | 5,243.9 | 5,243.9 | 4,796.4 | 5,278.1 | 5,278.1 | 5,278.1 | 5,020.8 | 3,840.9 | 3,840.9 |
| Operating Income | — | — | — | 6,554.0 | 6,806.4 | 6,155.5 | 7,229.9 | 5,265.9 | 3,276.3 | 3,374.0 | 3,374.0 | 2,790.0 | 5,408.2 | 5,408.2 | 4,901.5 | 5,349.5 | (1,307.6) | (1,307.6) |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 895.0 | 780.6 | 485.9 | 331.6 | 339.8 | 359.6 | 400.6 | 185.2 | 185.2 | 185.2 | 161.2 | 177.8 | 177.8 | 177.8 | 186.0 | (228.3) | — |
| Interest & Investment Income | — | — | 175.2 | 173.6 | 62.8 | 25.4 | 33.0 | 80.4 | 107.9 | 108.7 | 108.7 | 87.0 | 105.0 | 105.0 | 105.0 | 79.9 | (210.7) | — |
| Net Interest Expenses | — | — | — | 312.3 | 268.8 | 314.4 | 326.6 | 320.2 | 77.3 | 76.5 | 76.5 | 74.2 | 72.8 | 72.8 | 72.8 | 106.1 | (17.6) | — |
| Other Non-Operating Income / Expenses | (38.0) | (571.0) | (218.6) | 97.0 | (320.9) | (201.6) | 1,171.9 | 291.6 | 108.8 | (84.8) | (84.8) | 100.6 | 674.0 | 674.0 | 674.0 | (179.0) | 26.1 | — |
| Asset Writedown | — | — | — | — | — | — | — | 497.8 | (13.0) | 255.8 | 255.8 | 226.7 | 206.6 | 206.6 | 206.6 | 149.6 | 363.0 | — |
| EBT, Incl. Unusual Items | 33,595.0 | 25,731.0 | 12,680.4 | 6,554.0 | 6,806.4 | 6,155.5 | 7,229.9 | 1,663.1 | 931.6 | 284.1 | 892.0 | 444.6 | 5,408.2 | 5,408.2 | 5,408.2 | 5,349.5 | (1,307.6) | (1,307.6) |
| Income Tax Expense | 6,884.0 | 5,091.0 | 2,090.4 | 1,314.0 | 561.6 | 573.8 | 1,036.2 | 628.0 | 551.4 | 636.4 | 636.4 | 381.6 | 1,319.6 | 1,319.6 | 1,319.6 | 1,001.8 | 764.3 | 764.3 |
| Earnings from Continuing Operations | — | — | — | — | — | 5,581.7 | 6,193.7 | 4,637.9 | 2,724.9 | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||||
| Net Income | 26,711.0 | 20,640.0 | 10,590.0 | 5,240.0 | 6,244.8 | 5,581.7 | 6,193.7 | 8,318.4 | 2,737.6 | 2,737.6 | 2,737.6 | 2,408.4 | 4,088.6 | 4,088.6 | 4,088.6 | 4,347.7 | (2,071.9) | (2,071.9) |
| Per Share | ||||||||||||||||||
| Basic EPS | 29.93 | 23.00 | 11.76 | 5.82 | 6.93 | 6.15 | 6.82 | 8.93 | 2.59 | 2.59 | 2.59 | 2.27 | 3.67 | 3.67 | 3.67 | 3.90 | (1.89) | — |
| Diluted EPS | 29.89 | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 | 6.79 | 8.89 | 2.58 | 2.58 | 2.58 | 2.26 | 3.66 | 3.66 | 3.66 | 3.90 | (1.89) | — |
| Revenue per Share | 89.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 6.23 | 5.40 | 4.69 | 4.07 | 3.53 | 3.07 | 2.68 | 2.05 | — | — | — | — | — | — | 1.96 | 1.90 | — |
| Basic Weighted Avg Shares | 892.4 | 897.3 | 900.6 | 900.2 | 901.7 | 907.0 | 907.6 | 931.1 | 1,058.3 | 1,058.3 | 1,058.3 | 1,061.9 | 1,113.2 | 1,113.2 | 1,113.2 | 1,113.9 | 1,094.5 | — |
| Diluted Weighted Avg Shares | 893.7 | 899.3 | 904.1 | 903.3 | 904.6 | 911.7 | 912.5 | 935.7 | 1,061.8 | 1,061.8 | 1,061.8 | 1,065.7 | 1,117.3 | 1,117.3 | — | 1,114.0 | 1,094.5 | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | — | — | 8,081.0 | 8,328.9 | 7,703.1 | 8,553.8 | 6,498.5 | 4,772.9 | 4,870.6 | 4,870.6 | 4,217.7 | 6,870.4 | 6,870.4 | 6,363.7 | 6,723.1 | (185.0) | (2,430.2) |
| EBIT | — | — | — | 6,554.0 | 6,806.4 | 6,155.5 | 7,229.9 | 5,265.9 | 3,276.3 | 3,374.0 | 3,374.0 | 2,790.0 | 5,408.2 | 5,408.2 | 4,901.5 | 5,349.5 | (1,307.6) | (1,307.6) |
| Effective Tax Rate | 20.5% | — | — | 20.0% | 8.3% | 9.3% | 14.3% | 37.8% | 59.2% | 224.0% | 71.3% | 85.8% | 24.4% | 24.4% | 24.4% | 18.7% | -58.5% | -58.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.